Evan Levine, CEO & President at ADVENTRX PHARMACEUTICALS INC (ANX), sold 15,000 shares at $1.50 ($34K) on 2005-03-22, disclosed to the SEC on 2008-04-15.
Open-market sale of $34k ANX by CEO & President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.50 | 3,000 | $5K | 13.2% |
| 2 | $3.16 | 3,800 | $12K | 35.2% |
| 3 | $3.22 | 1,200 | $4K | 11.3% |
| 4 | $4.29 | 2,000 | $9K | 25.1% |
| 5 | $2.82 | 1,000 | $3K | 8.3% |
| 6 | $0.60 | 100 |
| $60 |
| 0.2% |
| 7 | $0.60 | 900 | $540 | 1.6% |
| 8 | $0.59 | 3,000 | $2K | 5.2% |
| Total | $2.28 avg | 15,000 | $34K | 100% |
| Filing → |
| ANX | BUY | 2007-12-17 | $27K | — | Filing → |
| QTXB | SELL | 2007-02-09 | $559K | — | Filing → |